CVE-2022-20870

Cisco IOS XE Software for Catalyst Switches MPLS Denial of Service Vulnerability

Description

A vulnerability in the egress MPLS packet processing function of Cisco IOS XE Software for Cisco Catalyst 3650, Catalyst 3850, and Catalyst 9000 Family Switches could allow an unauthenticated, remote attacker to cause an affected device to reload unexpectedly, resulting in a denial of service (DoS) condition. This vulnerability is due to insufficient input validation of IPv4 traffic. An attacker could exploit this vulnerability by sending a malformed packet out of an affected MPLS-enabled interface. A successful exploit could allow the attacker to cause the device to reload, resulting in a DoS condition.

Category

8.6
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.10%
Vendor Advisory cisco.com
Affected: Cisco Cisco IOS XE Software
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-20870?
CVE-2022-20870 has been scored as a high severity vulnerability.
How to fix CVE-2022-20870?
To fix CVE-2022-20870, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-20870 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-20870 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-20870?
CVE-2022-20870 affects Cisco Cisco IOS XE Software.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.